We are passionate about improving the future practice of healthcare by accelerating the rate of personalized medicine research & discovery. Our mission is to develop technologies for the analysis and organization of genomic information that will make this future a reality.
Founded in 2011, we are an interdisciplinary team of engineers, computer scientists, and genomicists, revolutionizing human genomics research. Bina was acquired by Roche in December 2014.
The word "Bina" means "knowledge" or "insight", translated from both Persian and Hebrew.
Next-generation sequencing and other high-throughput genomic measurement technologies are providing us with unprecedented visibility into the origins of health and disease. Understanding these datasets has the potential to create a paradigm shift in how we develop drugs, diagnose disease, prevent ailments, and treat patients, especially in complex cases such as cancer. What is needed now is an informatics solution with the ability to analyze, manage and share genomic information.
Our integrated, scalable, and comprehensive analysis platform empowers researchers and bioinformaticians to gain insight from their genomics data sets. Our products dramatically decrease the complexity, time, and cost of the analysis, accelerating the science of personalized medicine.
After many years of multidisciplinary research in systems biology and high performance computing, at both Stanford University and UC Berkeley, Narges founded Bina to begin applying those results to the world of genomics. She holds multiple patents, and has several publications, as well as a Masters and a PhD in Electrical Engineering from Stanford University. Narges loves spending time in nature and hiking, and enjoys Persian poetry and music.
Chad leads the product management team at Bina. Prior to joining Bina, he was Director of Product Management at Healthagen, a software innovation group at Aetna. He has over fifteen years of experience launching and managing successful software products in enterprise, consumer and healthcare verticals. He holds an MBA from Columbia Business School, as well as a BA and MA in philosophy from Western Michigan University. Chad is an avid mountain biker, hiker and backpacker. He is an aspiring mountain climber and also enjoys traveling, sci-fi and spicy food.
Hugo leads the science and bioinformatics teams at Bina, directing the research and development progress towards more accurate, robust and faster pipelines for analyzing and interpreting genomics data. He brings over ten years experience in IT and genomics, including time at 23andMe and Personalis. Hugo received his bachelor's degree in biology from the Hong Kong University of Science and Technology and his master's degree in computer science from the Imperial College London. He also holds a Ph.D. in Computational Biology and Bioinformatics from Yale and was a postdoctoral scholar in Bioinformatics at Stanford. In his free time, Hugo enjoys swimming and playing snookers.
Laurie leads the finance function at Bina. She joined Bina in April 2015 from the Roche Diagnostics affiliate based in Shanghai, China where she held finance leadership roles such as Senior Financial Controlling Manager and Senior Price Controlling Manager. Laurie worked for Roche in China close to 6 years and during that time, she was also sent on a short term finance assignment to Roche Pharma Sweden. Prior to Roche, she worked for Wuxi Pharmatech and KPMG. Laurie has received both her Bachelor’s and Master’s degrees in Business Administration from UC Berkeley’s Haas School of Business. She is also a California licensed CPA. In her spare time, Laurie loves to travel and is rediscovering the SF Bay Area after spending 8+ years abroad.
You can find us in person and hear more about what we're up to at a number of upcoming industry events.